NeuroAge hippocampus growth claim
The founder of longevity startup NeuroAge claimed to have grown her own hippocampus by 1.5%, though the claim is not clinically validated.
Where this was said
Inside Vitalist Bay: The Longevity Movement's Festival
At 5:40 · chapter starts 2:39
Sarah Todd, a health reporter for STAT News, went to Vitalist Bay expecting a sea of Bryan Johnson-style tech billionaires and found something more nuanced. The Berkeley-based conference, only in its second year, draws investors, researchers, and general wellness enthusiasts — and has a notably diverse crowd, including significant numbers of women and people of color. [1] — Sarah Todd "Vitalist Bay is a Berkeley-based annual gathering for the longevity movement — part science fair, part lifestyle festival. Attendees range …" 02:39 Todd discovered that attendees aren't primarily afraid of dying; instead, they're acutely aware of death and worried that the average human lifespan simply isn't long enough to do everything they want. Many had personal stakes — relatives with Alzheimer's or dementia — driving their interest in healthspan as well as lifespan. One company on the expo floor, NeuroAge, claimed its MRI and blood-test combination could measure brain biological age and that its founder had grown her own hippocampus by 1.5%, though the company acknowledged its methods aren't yet clinically validated.
Vitalist Bay: The Burning Man of Longevity
Vitalist Bay is a Berkeley-based annual gathering for the longevity movement — part science fair, part lifestyle festival. Attendees range from tech workers to researchers and investors, and the crowd is more diverse than the billionaire-bro stereotype suggests.
Vitalist Bay conference diversity
Sarah Todd found the Vitalist Bay longevity conference more diverse than expected, with a fair number of women and people of color, not just tech billionaires.
Bodyoids: Growing Headless Organ Farms for Immortality
Two startups at Vitalist Bay are building 'bodyoids' — headless biological sacks of organs that could replace failing human hearts, livers, and kidneys. The concept raises immediate philosophical alarm: if you replace enough organs, are you still you?
Similar snapshots
Psychological immune system works strongest on irreversible decisions
Dan Gilbert's research found that the psychological immune system — the brain's ability to justify and find satisfaction in choices — activates most powerfully when a decision is perceived as irreversible.
Maximizers earn more but are less happy than satisficers
Barry Schwartz's research found that maximizers — people who try to optimize every decision — tend to achieve objectively better outcomes but report lower happiness than satisficers who choose 'good enough.'
People regret inaction more than action long-term
Research consistently shows that while people may initially regret poor decisions, in the long run they regret the decisions they didn't make — inaction — far more than the ones they took.
Brief exposure to 10 attractive faces reduced relationship satisfaction
A study showed that men in committed relationships who briefly viewed 10 attractive women's faces reported a measurable decrease in relationship satisfaction immediately afterward, illustrating evolutionary mismatch with modern media.
Dan Gilbert proposed marriage after realizing constraints increase satisfaction
Harvard psychologist Dan Gilbert, who previously didn't believe in marriage, immediately proposed to his long-term girlfriend after his own research showed that constraints increase satisfaction with choices.
540M years ago: first animal vision
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
50% of cortex involved in vision
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Human 6-year-olds learn tens of thousands of object categories
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
~3% of FDA drugs have unclear mechanisms
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
